In summary, these reports corroborate our findings and reinforce the contribution of CCL2, CXCL8, CXCL10, and IL-18 for MPN pathogenesis by promoting hematopoietic niche modifications, activation of angiogenesis, and deregulation of hematopoiesis. The gene discussed is CCL2; the disease is myeloproliferative neoplasm.